As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
Reminder - On Wednesday June 6, 2018 at 10:00AM PST, we will be hosting a webinar regarding the chan...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
As the US coast prepares for Hurricane Florence to make landfall, we have received importan...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization